Pharmabiz

MOC’s first neighbourhood cancer treatment facility inaugurated in Delhi

MOC’s first neighbourhood cancer treatment facility inaugurated in Delhi: Our Bureau, Mumbai Monday, December 8, 2025, 14:45 ...
Pharmabiz

Lumov raises $1.2 mn seed round from Incubate Fund Asia & others to redefine orthopaedic recovery and rehabilitation in India

Lumov raises $1.2 mn seed round from Incubate Fund Asia & others to redefine orthopaedic recovery and rehabilitation in India: Our Bureau, Bengaluru Monday, December 8, 2025, 16:1 ...
Pharmabiz

MrMed strengthens India’s specialty-medicine network with new hub and Eli Lilly partnership

MrMed strengthens India’s specialty-medicine network with new hub and Eli Lilly partnership: Our Bureau, Bengaluru Monday, December 8, 2025, 16:30 Hrs [IST] MrMed, India’s onl ...
Pharmabiz

Trivitron unveils its Digital.AI to propel hospital digitization and clinical interoperability in India

Trivitron unveils its Digital.AI to propel hospital digitization and clinical interoperability in India: Our Bureau, Bengaluru Monday, December 8, 2025, 16:20 Hrs [IST] Trivitron ...
Pharmabiz

OS Therapies announces US FDA PDUFA waiver & EMA grants Union Marketing Authorisation eligibility for OST-HERs

OS Therapies announces US FDA PDUFA waiver & EMA grants Union Marketing Authorisation eligibility for OST-HERs: New York Monday, December 8, 2025, 16:00 Hrs [IST] OS Therapies Inc ...
Pharmabiz

HRV Pharma bags Great Place To Work Status for 2025–2026, underscoring trust and inclusivity at the workplace

HRV Pharma bags Great Place To Work Status for 2025–2026, underscoring trust and inclusivity at the workplace: Our Bureau, Bengaluru Monday, December 8, 2025, 14:30 Hrs [IST] HR ...
Pharmabiz

SSO secures $2.8 million in funding from the Everhope Oncology platform to accelerate its next phase of growth

SSO secures $2.8 million in funding from the Everhope Oncology platform to accelerate its next phase of growth: Our Bureau, Bengaluru Monday, December 8, 2025, 14:15 Hrs [IST] Spe ...
Pharmabiz

Replicate Bioscience & Instituto Butantan ink collaboration to develop and commercialize Replicate’s srRNA rabies vaccine in Latin America

Replicate Bioscience & Instituto Butantan ink collaboration to develop and commercialize Replicate’s srRNA rabies vaccine in Latin America: San Diego, California Monday, Decembe ...
Pharmabiz

Natus Medical’s BrainWatch point-of-care EEG solution receives US FDA 510(k) clearance

Natus Medical’s BrainWatch point-of-care EEG solution receives US FDA 510(k) clearance: Middleton, Wisconsin Monday, December 8, 2025, 15:00 Hrs [IST] Natus Medical Incorporated ...
Pharmabiz

Senores Pharma receives Philippine FDA approval for 10 products

Senores Pharma receives Philippine FDA approval for 10 products: Our Bureau, Bengaluru Monday, December 8, 2025, 13:50 Hrs [IST] Senores Pharmaceuticals has received marketing aut ...
Pharmabiz

Indo–Italian medical consensus sounds alarm on paediatric sarcoma; experts urge action on early diagnosis

Indo–Italian medical consensus sounds alarm on paediatric sarcoma; experts urge action on early diagnosis: Our Bureau, Bengaluru Monday, December 8, 2025, 13:40 Hrs [IST] IndoIt ...
Pharmabiz

US FDA launches TEMPO: A first-of-its-kind digital health pilot to expand access to chronic disease technologies

A first-of-its-kind digital health pilot to expand access to chronic disease technologies: Silver Spring, Maryland Monday, December 8, 2025, 13:00 Hrs [IST] ...